Chronic diabetic wounds are frequently complicated by bacterial infection and impaired healing. The authors previously reported that 5-aminolevulinic acid (ALA)-mediated photodynamic therapy (PDT) reduced microbial burden and promoted healing in chronic diabetic wounds. Because the antibacterial effect of ALA-PDT can be limited by restricted light penetration into tissues, this study assessed whether combining ALA-PDT with the antibiotic ceftazidime could increase antimicrobial efficacy and improve wound healing in the setting of multidrug-resistant Pseudomonas aeruginosa infection.
The study found that combination treatment with ALA-PDT plus ceftazidime produced a synergistic inhibition of growth of multidrug-resistant P. aeruginosa compared with either modality alone. The abstract reports synergy as a major finding but does not provide specific fractional inhibitory concentration indices, minimal inhibitory concentrations, concentrations used, or statistical details; those experimental specifics were not reported in the abstract.
Beyond planktonic killing, the combination therapy prevented biofilm formation, an important contributor to chronic wound persistence and antibiotic tolerance. The combined treatment also inactivated the virulence-associated pigment pyocyanin, delayed the development of antibiotic resistance, and produced a prolonged post-antibiotic effect. The abstract summarizes these functional outcomes without quantitative values or timelines; the underlying experimental parameters were not described in the abstract.
Mechanistic data support the antimicrobial synergy. The authors attribute the enhanced bactericidal activity to ALA-PDT-mediated reactive oxygen species (ROS) production, which led to structural damage of bacterial cells and increased membrane permeability. These changes plausibly facilitated greater cellular uptake of ceftazidime, thereby enhancing antibiotic activity. The abstract identifies these mechanistic observations but does not include the specific assays, ROS measures, or membrane-permeability metrics used.
In a diabetic rat model with a full-thickness skin defect infected with multidrug-resistant P. aeruginosa, the combination therapy group showed the highest bactericidal effect and the most pronounced wound closure rates among the groups tested. These in vivo outcomes link the in vitro synergy and mechanistic findings to improved infection control and tissue repair in an animal model of diabetic wound infection. The abstract does not report numerical wound-closure percentages, time courses, bacterial counts, or group sizes.
To explore host responses, the authors performed transcriptomic analysis on wound tissues comparing the combination therapy group with the untreated model group. Differentially expressed genes were mainly enriched in the IL-17, AKT-STAT, and VEGF signaling pathways. The abstract reports pathway-level enrichment but does not list individual genes, fold changes, or statistical thresholds used for differential expression.
Molecular experiments indicated that combination therapy may modulate key signaling nodes involved in inflammation and repair. Specifically, the authors observed regulation of IL-17, activation of the JAK-STAT axis with increased phosphorylated JAK2 (p-JAK2) and phosphorylated STAT3 (p-STAT3), and decreased expression of SOCS3. Downstream, these changes were associated with upregulation of Ki-67, CD31, and VEGF, consistent with enhanced cell proliferation, angiogenesis, and tissue regeneration. The abstract links these molecular changes to observed increases in angiogenesis, collagen deposition, and wound healing, but it does not provide quantitative expression data, blot images, or immunohistochemical scoring in the abstract itself.
The authors conclude that combining PDT with an antibiotic—here, ALA-PDT plus ceftazidime—is an effective strategy to treat infections in diabetic wounds infected with multidrug-resistant P. aeruginosa. The proposed benefits include direct bacterial killing, inhibition of biofilm formation, attenuation of virulence factors, slowing of resistance emergence, and promotion of wound repair via modulation of inflammatory and pro-angiogenic signaling pathways.
The abstract does not report detailed experimental parameters such as ALA dose, light wavelength and fluence, ceftazidime dosing, timing and frequency of treatments, sample sizes, quantitative outcome measures, or statistical analyses. Those specifics and full data would need to be consulted in the full text for evaluation of translational potential and reproducibility.
This preclinical report supports a combined antimicrobial and host-directed approach to infected diabetic wounds, using photochemical bacterial inactivation to potentiate antibiotic uptake and simultaneously promote repair-associated signaling. Further details from the full publication would be required to assess safety, dosing regimens, and feasibility for clinical translation.